Stock CCAP CRESCENT CAPITAL BDC, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Crescent Capital BDC, Inc.

Equities

CCAP

US2256551092

Delayed Nasdaq
Other stock markets
 01:12:04 2024-05-02 pm EDT 		5-day change 1st Jan Change
17.35 USD -0.06% Intraday chart for Crescent Capital BDC, Inc. +0.64% -0.17%
Feb. 23 Oppenheimer Adjusts Crescent Capital BDC Price Target to $19 From $18, Maintains Outperform Rating MT
Feb. 22 Transcript : Crescent Capital BDC, Inc., Q4 2023 Earnings Call, Feb 22, 2024

Evolution of the average Target Price on Crescent Capital BDC, Inc.

Price target over the last 5 years

History of analyst recommendation changes

ab8f6df1c818338635e1d.1F9LPK73XOlKQoQMEV8duxtP8AkQAGkb0CXfh_pFwcw.jhoUDv6CC6YkNLF1WT146Xh2gUdXMAF8uU7r07Itm5idajx4_LZtnnN7yQ~2ece5987febc895dfba3c2a3f266ef3f

Analyst Recommendations on Crescent Capital BDC, Inc.

Oppenheimer Adjusts Crescent Capital BDC Price Target to $19 From $18, Maintains Outperform Rating MT
Wells Fargo Raises Price Target on Crescent Capital BDC to $16.50 From $16, Maintains Equalweight Rating MT
Wells Fargo Downgrades Crescent Capital BDC to Equal-Weight From Overweight, Trims Price Target to $16 From $16.50 MT
Keefe, Bruyette & Woods Starts Crescent Capital BDC at Outperform With $18 Price Target MT
Oppenheimer Adjusts Crescent Capital BDC Price Target to $18 From $19, Maintains Outperform Rating MT
Raymond James Adjusts Crescent Capital's Price Target to $18 from $20.50, Retains Outperform Rating MT
Oppenheimer Upgrades Crescent Capital BDC to Outperform From Perform, Trims Price Target to $19 From $20 MT
Raymond James Trims Crescent Capital's Price Target to $20.50 From $21, Maintains Outperform Rating MT
Wells Fargo Adjusts Crescent Capital BDC's Price Target to $18.50 from $19.50, Keeps Overweight Rating MT
Wells Fargo Starts Crescent Capital BDC at Overweight With $19.50 Price Target MT
BofA Securities Starts Crescent Capital BDC at Buy With $19.50 Price Target MT
CRESCENT CAPITAL BDC : Oppenheimer Lifts Price Target on Crescent Capital BDC to $20 From $19, Keeps Perform Rating MT
CRESCENT CAPITAL BDC : Oppenheimer Initiates Coverage on Crescent Capital BDC With Perform Rating, $19 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
17.36 USD
Average target price
18 USD
Spread / Average Target
+3.69%
High Price Target
19 USD
Spread / Highest target
+9.45%
Low Price Target
16.5 USD
Spread / Lowest Target
-4.95%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Crescent Capital BDC, Inc.

Oppenheimer
Wells Fargo Securities
Keefe, Bruyette & Woods
Raymond James
BofA Securities

Ratings for Crescent Capital BDC, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. CCAP Stock
  4. Consensus Crescent Capital BDC, Inc.